Based on the current information, a very large amount of BRCA1 together with other effectors (e.g., BRCA2) appeared in balloon hepatic cells from liver injury by an unknown mechanism that likely arose through adaptive evolution, which mediated downstream gene expression and prevented BRCA1-related cancer. The gene discussed is BRCA2; the disease is cancer.